Biopharma companies have an increasing dependence on in-licensing and acquisitions to grow their portfolios and bridge their pipeline gaps. To increase their probability of success, Quintiles offers a due diligence solution that provides an objective data supported evaluation process provided by our flexible and adaptable team of experts that have vast clinical and commercial experience.

The Quintiles Technical & Commercial Due Diligence Solution provides biopharma clients with objective evaluations empowering them to make more accurate decisions using real-world data and analytics. 

Powerful benefits:

  • Integrated strategic consulting capabilities across multiple scientific and commercial disciplines
  • Tailored and scalable process for asset evaluation and due diligence
  • Industry leading strategic drug development experts (functional and disease-specific) that allow our clients to obtain the relevant insights, enabling more accurate determination of asset value
  • Extensive commercial and consulting experience leverages Quintiles’ access to proprietary and subscription databases which enables our team of experts to deliver commercial strategy, forecasting, and valuation
  • Rapid and comprehensive assessments meet the transaction timelines